After settlement Mylan stocks up more than 10%: 4 thoughts

TheStreet is reporting that investors bid up Mylan’s stock after the pharmaceutical company settled with the U.S. Department of Justice.

Advertisement

Here’s what you need to know.

1. Before market open Monday, the stock jumped 12 percent hitting $35.94 a share.

2. After the market opened, the stock jumped 10 percent to $39.49 a share.

3. Mylan is still being investigated by the Minnesota and New York Attorney Generals.

4. Randall Stanicky, an analyst with RBC Capital Markets said the company’s stock will decrease in the coming weeks.

More coding, billing and collections news:
6 things to know about what the government is doing to people who lost coverage through the ACA
Mylan agrees to pay $465M in settlement with feds: 8 notes
Repeal it or fix it? 2nd presidential debate fires up with ACA debate

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Coding, Billing & Collections

Advertisement

Comments are closed.